Long-Term Treatment with Cannabidiol-Enriched Cannabis Extract Induces Synaptic Changes in the Adolescent Rat Hippocampus

• Published in: International journal of molecular sciences 2023-07, Vol.24 (14), p.11775
• Main Authors: Aguiar, Andrey F L, Campos, Raquel M P, Isaac, Alinny R, Paes-Colli, Yolanda, Carvalho, Virgínia M, Sampaio, Luzia S, de Melo Reis, Ricardo A
• Format: Article
• Language: English
• Subjects: Animals; Cannabidiol; Cannabis; Child development; endocannabinoid system; Food; Marijuana; Metabolites; Neurosciences; Synapses; synaptic changes; Tetrahydrocannabinol; THC; Urine; Young adults
• ISSN: 1422-0067; 1661-6596; 1422-0067
• DOI: 10.3390/ijms241411775

The endocannabinoid system (eCS) is widely distributed in mammalian tissues and it is classically formed by cannabinoid receptors, endogenous bioactive lipids and its synthesis and degradation enzymes. Due to the modulatory role of eCS in synaptic activity in the Central Nervous System (CNS), phytocannabinoids have been increasingly used for the treatment of neurological disorders, even though little is known in terms of the long-term effect of these treatments on CNS development, mainly in the timeframe that comprises childhood and adolescence. Furthermore, an increased number of clinical trials using full-spectrum extracts has been seen, rather than the isolated form of phytocannabinoids, when exploring the therapeutical benefits of the plant. Thus, this study aims to evaluate the effect of cannabidiol (CBD)-enriched extract on synaptic components in the hippocampus of rats from adolescence to early adulthood (postnatal day 45 to 60). Oral treatment of healthy male Wistar rats with a CBD-enriched extract (3 mg/kg/day CBD) during 15 days did not affect food intake and water balance. There was also no negative impact on locomotor behaviour and cognitive performance. However, the hippocampal protein levels of GluA1 and GFAP were reduced in animals treated with the extract, whilst PSD95 levels were increased, which suggests rearrangement of glutamatergic synapses and modulation of astrocytic features. Microglial complexity was reduced in CA1 and CA3 regions, but no alterations in their phagocytic activity have been identified by Iba-1 and LAMP2 co-localization. Collectively, our data suggest that CBD-enriched treatment may be safe and well-tolerated in healthy subjects, besides acting as a neuroprotective agent against hippocampal alterations related to the pathogenesis of excitatory and astrogliosis-mediated disorders in CNS.